Commentary
In this text, D. García-Compeán and A. R. Jiménez-Rodríguez (University Hospital “Dr. José E. González” and, Universidad Autónoma de Nuevo León, Monterrey, Mexico) discuss, in general terms, the clinical evidence generated to date in cross-sectional and longitudinal studies focusing on clinical characteristics and outcomes, mainly on all-cause and specific mortality of MAFLD.
Previous Post
COVID-19, mortality and NAFLD
Next Post
NAFLD and adverse pregnancy outcomes